Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
出版年份 2021 全文链接
标题
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
作者
关键词
-
出版物
DRUGS
Volume 81, Issue 11, Pages 1273-1284
出版商
Springer Science and Business Media LLC
发表日期
2021-07-01
DOI
10.1007/s40265-021-01556-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Polypharmacy in schizophrenia
- (2020) Lone Baandrup BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- 20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)
- (2020) Heidi Taipale et al. World Psychiatry
- Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
- (2020) Robert A. McCutcheon et al. World Psychiatry
- Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
- (2020) Roos van Westrhenen et al. Frontiers in Psychiatry
- The polygenic architecture of schizophrenia — rethinking pathogenesis and nosology
- (2020) Olav B. Smeland et al. Nature Reviews Neurology
- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia
- (2020) George A. Keepers et al. AMERICAN JOURNAL OF PSYCHIATRY
- Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia
- (2019) Jari Tiihonen et al. JAMA Psychiatry
- Association Between Antipsychotic Polypharmacy and Outcomes for People With Serious Mental Illness in England
- (2019) Panagiotis Kasteridis et al. PSYCHIATRIC SERVICES
- Autoimmune Diseases and Psychotic Disorders
- (2019) Rose Jeppesen et al. Frontiers in Psychiatry
- Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis
- (2019) Kentaro Matsui et al. SCHIZOPHRENIA RESEARCH
- A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments
- (2019) Maria J. Arranz et al. Translational Psychiatry
- Non-Genetic Factors in Schizophrenia
- (2019) Simona A. Stilo et al. Current Psychiatry Reports
- Sex-specific transcriptional and proteomic signatures in schizophrenia
- (2019) Jari Tiihonen et al. Nature Communications
- Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey
- (2019) Min Dong et al. Asian Journal of Psychiatry
- Antipsychotic Polypharmacy: A Dirty Little Secret or a Fashion?
- (2019) Shih-Ku Lin INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Long-term antipsychotic polypharmacy prescribing in secondary mental health care and the risk of mortality
- (2018) G. Kadra et al. ACTA PSYCHIATRICA SCANDINAVICA
- Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses
- (2018) Berta Moreno-Küstner et al. PLoS One
- Is the risk of antipsychotic polypharmacy discontinuation dependent on the agents used?
- (2018) Robert J. Constantine et al. PSYCHIATRY RESEARCH
- Early Intervention and a Direction of Novel Therapeutics for the Improvement of Functional Outcomes in Schizophrenia: A Selective Review
- (2018) Masayoshi Kurachi et al. Frontiers in Psychiatry
- Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis
- (2018) C. Okhuijsen-Pfeifer et al. ACTA PSYCHIATRICA SCANDINAVICA
- Treatment of Benzodiazepine Dependence
- (2017) Michael Soyka NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetic considerations in antipsychotic augmentation strategies: How to combine risperidone with low-potency antipsychotics
- (2017) Michael Paulzen et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Antipsychotic polypharmacy prescribing and risk of hospital readmission
- (2017) Giouliana Kadra et al. PSYCHOPHARMACOLOGY
- Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia—A Nationwide Study With 20-Year Follow-up
- (2017) Heidi Taipale et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic medication and remission of psychotic symptoms 10 years after a first-episode psychosis
- (2017) Regitze Sølling Wils et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis
- (2017) Britta Galling et al. World Psychiatry
- Schizophrenia and the neurodevelopmental continuum:evidence from genomics
- (2017) Michael J. Owen et al. World Psychiatry
- Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia
- (2017) Christoph U. Correll et al. JAMA Psychiatry
- Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia
- (2017) Jari Tiihonen et al. JAMA Psychiatry
- Trial exclusion criteria and their impact on the estimation of antipsychotic drugs effect: A case study using the SOHO database
- (2017) Clementine Nordon et al. SCHIZOPHRENIA RESEARCH
- Risperidone-induced extrapyramidal side effects
- (2016) Georgios Schoretsanitis et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Switching From 2 Antipsychotics to 1 Antipsychotic in Schizophrenia
- (2016) Carol Borlido et al. JOURNAL OF CLINICAL PSYCHIATRY
- Schizophrenia
- (2016) Michael J Owen et al. LANCET
- Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis
- (2016) Jian-Ping Zhang et al. SCHIZOPHRENIA BULLETIN
- Predictors of long-term (≥ 6 months) antipsychotic polypharmacy prescribing in secondary mental healthcare
- (2016) Giouliana Kadra et al. SCHIZOPHRENIA RESEARCH
- Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: A systematic review and meta-analysis of randomized-controlled trials
- (2015) Manit Srisurapanont et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Inflammation in schizophrenia: A question of balance
- (2015) Juan C. Leza et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: A randomized controlled trial
- (2015) Robert J. Constantine et al. SCHIZOPHRENIA RESEARCH
- A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results
- (2015) Tessa Kennedy-Martin et al. Trials
- The role of inflammation in schizophrenia
- (2015) Norbert Müller et al. Frontiers in Neuroscience
- Schizophrenia
- (2015) René S. Kahn et al. Nature Reviews Disease Primers
- Polypharmacy for schizophrenia
- (2013) Jacob Ballon et al. CURRENT OPINION IN PSYCHIATRY
- Antipsychotic combination using low-dose antipsychotics is as efficacious and safe as, but cheaper, than optimal-dose monotherapy in the treatment of schizophrenia
- (2013) Ching-Hua Lin et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Using Treatment Response to Subtype Schizophrenia: Proposal for a New Paradigm in Classification
- (2013) S. Farooq et al. SCHIZOPHRENIA BULLETIN
- Real-world effectiveness of antipsychotic monotherapy vs. polypharmacy in schizophrenia: To switch or to combine? A nationwide study in Hungary
- (2013) Lajos Katona et al. SCHIZOPHRENIA RESEARCH
- Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies
- (2013) John M. Kane et al. World Psychiatry
- Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy
- (2013) Lex Wunderink et al. JAMA Psychiatry
- Polypharmacy With Antipsychotics, Antidepressants, or Benzodiazepines and Mortality in Schizophrenia
- (2012) Jari Tiihonen ARCHIVES OF GENERAL PSYCHIATRY
- Safety and tolerability of antipsychotic polypharmacy
- (2012) Juan A Gallego et al. Expert Opinion On Drug Safety
- Critical review of antipsychotic polypharmacy in the treatment of schizophrenia
- (2012) W. Wolfgang Fleischhacker et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Prevalence and correlates of antipsychotic polypharmacy: A systematic review and meta-regression of global and regional trends from the 1970s to 2009
- (2012) Juan A. Gallego et al. SCHIZOPHRENIA RESEARCH
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Augmentation of clozapine with a second antipsychotic - a meta-analysis
- (2011) D. M. Taylor et al. ACTA PSYCHIATRICA SCANDINAVICA
- Effectiveness of Switching From Antipsychotic Polypharmacy to Monotherapy
- (2011) Susan M. Essock et al. AMERICAN JOURNAL OF PSYCHIATRY
- How Dosing Might Influence the Conclusion in an Antipsychotic Polypharmacy Effectiveness Trial
- (2011) Lone Baandrup AMERICAN JOURNAL OF PSYCHIATRY
- An Algorithm-Based Approach to First-Episode Schizophrenia
- (2011) Ofer Agid et al. JOURNAL OF CLINICAL PSYCHIATRY
- Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature Review
- (2011) Iris E. Sommer et al. SCHIZOPHRENIA BULLETIN
- Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study
- (2011) Maria Rosaria A. Muscatello et al. SCHIZOPHRENIA RESEARCH
- Doubtful association of antipsychotic polypharmacy and high dosage with cognition in chronic schizophrenia
- (2010) Dimitrios Kontis et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Augmentation of clozapine with a second antipsychotic - a meta-analysis of randomized, placebo-controlled studies
- (2009) D. M. Taylor et al. ACTA PSYCHIATRICA SCANDINAVICA
- Benefits and Risks of Antipsychotic Polypharmacy
- (2009) Constantin Tranulis et al. DRUG SAFETY
- Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory Schizophrenia
- (2009) Jae Seung Chang et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antipsychotic Polypharmacy and Risk of Death From Natural Causes in Patients With Schizophrenia
- (2009) Lone Baandrup et al. JOURNAL OF CLINICAL PSYCHIATRY
- Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder
- (2009) D. Élie et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials
- (2008) C. U. Correll et al. SCHIZOPHRENIA BULLETIN
- Does the Addition of a Second Antipsychotic Drug Improve Clozapine Treatment?
- (2008) C. Barbui et al. SCHIZOPHRENIA BULLETIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now